Side-by-side financials for ALGS and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALGS | RVMD |
|---|---|---|
| Market cap | - | $31.73 B |
| US-listed rank | - | #448 |
| Revenue (latest FY) | $2.19M | $0.00 |
| Net income (latest FY) | -$24.19M | -$1.13B |
| Net margin | -1106.7% | - |
| SEC filings | 334 | 782 |
In their latest fiscal years, Aligos Therapeutics, Inc. reported $2.19M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Aligos Therapeutics, Inc. and Revolution Medicines, Inc., or browse the full rankings.